In vivo anti-melanoma activities of the Melan-A/MART-1101–115 T CD4+ cell peptide-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In vivo anti-melanoma activities of the Melan-A/MART-1101–115 T CD4+ cell peptide

Published:2009-10 Issue:44 Volume:27 Page:6107-6109
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Balasse Emilie,Gatouillat Gregory,Patigny Dominique,Andry Marie Christine,Madoulet Claudie

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference24 articles.

1. Computational peptide dissection of Melan-a/MART-1 oncoprotein antigenicity;Tiwari;Peptides,2004

2. Melan-A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution;Hofbauer;Melanoma Res,1998

3. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes;Kawakami;J Exp Med,1994

4. Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes;Castelli;J Exp Med,1995

5. Identification of five new HLA-B*3501-restricted epitopes derived from common melanoma-associated antigens, spontaneously recognized by tumor-infiltrating lymphocytes;Benlalam;J Immunol,2003

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Tumor Antigen‐Based Anticancer Immunotherapy: Recent Progress, Prevailing Challenges, and Future Perspective;Advanced Therapeutics;2022-12-08

2. Immunogenicity, Immunopathogenicity, and Immunotolerance in One Graph;Anti-Cancer Agents in Medicinal Chemistry;2015-10-07

3. Process development and production of cGMP grade Melan-A for cancer vaccine clinical trials;Protein Expression and Purification;2013-12

4. Current World Literature;Current Opinion in Oncology;2011-03

5. Current World Literature;Current Opinion in Supportive & Palliative Care;2010-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3